Literature for LB30057 (S01.217 inhibitor)
(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Kang,K.W., Choi,S.Y., Cho,M.K., Lee,C.H. and Kim,S.G.
Thrombin induces nitric-oxide synthase via Galpha12/13-coupled protein kinase C-dependent I-kappaBalpha phosphorylation and JNK-mediated I-kappaBalpha degradation
J Biol Chem278, 17368-17378. PubMed Europe PubMed DOI I -
Oh,Y.S., Yun,M., Hwang,S.Y., Hong,S., Shin,Y., Lee,K., Yoon,K.H., Yoo,Y.J., Kim,D.S., Lee,S.H., Lee,Y.H., Park,H.D., Lee,C.H., Lee,S.K. and Kim,S.
Discovery of LB30057, a benzamidrazone-based selective oral thrombin inhibitor
Bioorg Med Chem Lett8, 631-634. PubMed Europe PubMed DOI I
2003
1998
